4th Quarter - Report
LMH STRATEGIC SOLUTIONS for GLAXOSMITHKLINE LLC
Client
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALANNA TEMME | Legislative Director, U.S. Representative Jon Porter |
Pharmacy PHA
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALANNA TEMME | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.